You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-CD45 antibody (ab10559)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-CD45 antibody
See all CD45 products (76) ...

Description

Rabbit polyclonal to CD45

Tested applications

WB, Flow Cyt, ICC, IHC-Pmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide conjugated to KLH derived from within residues 1250 to the C-terminus of Human CD45.

(Peptide available as ab17550.)

Positive control

This antibody gave a positive signal in Jurkat whole cell lysate and Hodgkins lymphoma tissue sections.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 1% BSA, PBS, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • - CD45 antibody (ab10559)- CD45 antibody (ab10559) image (enlarge)

  • Flow Cytometry - CD45 antibody (ab10559)Flow Cytometry - CD45 antibody (ab10559) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CD45 antibody (ab10559)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CD45 antibody (ab10559) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab10559 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN.

Involvement in disease

Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+) SCID) [MIM:608971]. A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.
Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.

Sequence similarities

Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.
Contains 2 fibronectin type-III domains.
Contains 2 tyrosine-protein phosphatase domains.

Domain

The first PTPase domain interacts with SKAP1.

Post-translational
modifications

Heavily N- and O-glycosylated.

Cellular localization

Membrane. Membrane raft. Colocalized with DPP4 in membrane rafts.

Target information above from: UniProt accessionP08575 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • B220 antibody
  • CD 45 antibody
  • CD45 antibody
  • CD45 antigen antibody
  • CD45R antibody
  • GP180 antibody
  • L CA antibody
  • L-CA antibody
  • LCA antibody
  • Leukocyte common antigen antibody
  • LY5 antibody
  • OTTHUMP00000033813 antibody
  • OTTHUMP00000033816 antibody
  • OTTHUMP00000033817 antibody
  • OTTHUMP00000038574 antibody
  • Protein tyrosine phosphatase receptor type C antibody
  • Protein tyrosine phosphatase receptor type c polypeptide antibody
  • protein tyrosine phosphatase, receptor type, C antibody
  • PTPRC antibody
  • PTPRC_HUMAN antibody
  • Receptor-type tyrosine-protein phosphatase C antibody
  • SCID due to PTPRC deficiency antibody
  • T200 antibody
  • T200 glycoprotein antibody
  • T200 leukocyte common antigen antibody
see all

Anti-CD45 antibody images:

  - CD45 antibody (ab10559)

- CD45 antibody (ab10559)

ab10559  rabbit polyclonal to CD45  (1/500) with secondary goat anti-rabbit IgG ab6721 (1/5000).

Expected molecular weight: 147 kDa. WB exposure time: 1min 30sec    

Lanes 1 to 10: 20µg of cell lysate per lane
Lanes 6 to 10: ab17550 CD45 blocking peptide used at 1µg/ml

Lane 1: HeLa Nuclear Extract (ab10559)
Lane 2: HeLa Whole Cell Lysate (ab10559)
Lane 3: A431 Whole Cell Lysate (ab10559)
Lane 4: Jurkat Whole Cell Lysate (ab10559)
Lane 5: HEK293 Whole Cell Lysate (ab10559)
Lane 6: HeLa Nuclear Extract (ab10559+ ab17550)
Lane 7: HeLa Whole Cell Lysate (ab10559+ ab17550)
Lane 8: A431 Whole Cell Lysate (ab10559+ ab17550)
Lane 9: Jurkat Whole Cell Lysate (ab10559+ ab17550)
Lane 10: HEK293 Whole Cell Lysate (ab10559+ ab17550)

A strong band, slightly higher was seen in Jurkat cell lysate. The band was blocked using the immunising peptide (ab17550). It is likely that the band is CD45.

  Flow Cytometry - CD45 antibody (ab10559)

Flow Cytometry - CD45 antibody (ab10559)

Asynchronous KM-H2 cells were pelleted and labeled by indirect immunofluorescence. Cells were stained with ab10559 (1/200) for 30min at 4'C, washed and then stained with goat anti-rabbit alexafluor 488 (1/200). Forward/Side scatter were used to eliminate cellular debris. The accompanying marker was applied such that only 2% of the IgG control was positive. Based on the accompanying image, approximately 9.62% of cells exhibited positive staining for anti-CD45. Since KM-H2 have low levels of CD45 transcripts, it is expected that they have low levels of CD45 on their surface which is reflected in the ~9% positive. This image is taken from an Abreview.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CD45 antibody (ab10559)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - CD45 antibody (ab10559)

IHC image of CD45 staining in human Hodgkins lymphoma FFPE section, performed on a BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab10559, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

References for Anti-CD45 antibody (ab10559)

This product has been referenced in:

  • Cui Let al. Sublethal total body irradiation leads to early cerebellar damage and oxidative stress. Curr Neurovasc Res 7:125-35 (2010). IHC-P; Mouse.Read more (PubMed: 20334614) »

See 1 publication for this product

Publishing research using ab10559? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"